152 related articles for article (PubMed ID: 12102724)
41. New biomarkers of Maillard reaction damage to proteins.
Wells-Knecht KJ; Brinkmann E; Wells-Knecht MC; Litchfield JE; Ahmed MU; Reddy S; Zyzak DV; Thorpe SR; Baynes JW
Nephrol Dial Transplant; 1996; 11 Suppl 5():41-7. PubMed ID: 9044306
[TBL] [Abstract][Full Text] [Related]
42. Understanding non-enzymatic aminophospholipid glycation and its inhibition. Polar head features affect the kinetics of Schiff base formation.
Caldés C; Vilanova B; Adrover M; Muñoz F; Donoso J
Bioorg Med Chem; 2011 Aug; 19(15):4536-43. PubMed ID: 21719301
[TBL] [Abstract][Full Text] [Related]
43. Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to Nepsilon-carboxymethyl-lysine- and Nepsilon-(1-carboxyethyl)lysine-modified albumin.
Ahmed N; Argirov OK; Minhas HS; Cordeiro CA; Thornalley PJ
Biochem J; 2002 May; 364(Pt 1):1-14. PubMed ID: 11988070
[TBL] [Abstract][Full Text] [Related]
44. Analysis of protein glycation products by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
Kislinger T; Humeny A; Pischetsrieder M
Curr Med Chem; 2004 Aug; 11(16):2185-93. PubMed ID: 15279557
[TBL] [Abstract][Full Text] [Related]
45. Substituted benzenediol Schiff bases as promising new anti-glycation agents.
Choudhary MI; Abbas G; Ali S; Shuja S; Khalid N; Khan KM; Atta-ur-Rahman ; Basha FZ
J Enzyme Inhib Med Chem; 2011 Feb; 26(1):98-103. PubMed ID: 20583858
[TBL] [Abstract][Full Text] [Related]
46. Glycoxidation of biological macromolecules: a critical approach to halt the menace of glycation.
Ahmad S; Khan MS; Akhter F; Khan MS; Khan A; Ashraf JM; Pandey RP; Shahab U
Glycobiology; 2014 Nov; 24(11):979-90. PubMed ID: 24946787
[TBL] [Abstract][Full Text] [Related]
47. Rutin metabolites: novel inhibitors of nonoxidative advanced glycation end products.
Pashikanti S; de Alba DR; Boissonneault GA; Cervantes-Laurean D
Free Radic Biol Med; 2010 Mar; 48(5):656-63. PubMed ID: 19969069
[TBL] [Abstract][Full Text] [Related]
48. Pathologic role of dietary advanced glycation end products in cardiometabolic disorders, and therapeutic intervention.
Yamagishi S; Matsui T
Nutrition; 2016 Feb; 32(2):157-65. PubMed ID: 26602289
[TBL] [Abstract][Full Text] [Related]
49. Pathways of formation of glycoxidation products during glycation of collagen.
Wells-Knecht MC; Thorpe SR; Baynes JW
Biochemistry; 1995 Nov; 34(46):15134-41. PubMed ID: 7578127
[TBL] [Abstract][Full Text] [Related]
50. Monitoring glycation of lysozyme by electrospray ionization mass spectrometry.
Yeboah FK; Alli I; Yaylayan VA; Konishi Y; Stefanowicz P
J Agric Food Chem; 2000 Jul; 48(7):2766-74. PubMed ID: 10898620
[TBL] [Abstract][Full Text] [Related]
51. The Amadori product on protein: structure and reactions.
Baynes JW; Watkins NG; Fisher CI; Hull CJ; Patrick JS; Ahmed MU; Dunn JA; Thorpe SR
Prog Clin Biol Res; 1989; 304():43-67. PubMed ID: 2675036
[TBL] [Abstract][Full Text] [Related]
52. NMR analysis of synthetic human serum albumin alpha-helix 28 identifies structural distortion upon amadori modification.
Howard MJ; Smales CM
J Biol Chem; 2005 Jun; 280(24):22582-9. PubMed ID: 15837789
[TBL] [Abstract][Full Text] [Related]
53. Site-specific synthesis of Amadori-modified peptides on solid phase.
Frolov A; Singer D; Hoffmann R
J Pept Sci; 2006 Jun; 12(6):389-95. PubMed ID: 16342332
[TBL] [Abstract][Full Text] [Related]
54. Aminoguanidine pyridoxal adduct is superior to aminoguanidine for preventing diabetic nephropathy in mice.
Miyoshi H; Taguchi T; Sugiura M; Takeuchi M; Yanagisawa K; Watanabe Y; Miwa I; Makita Z; Koike T
Horm Metab Res; 2002 Jul; 34(7):371-7. PubMed ID: 12189584
[TBL] [Abstract][Full Text] [Related]
55. Transglycation--a potential new mechanism for deglycation of Schiff's bases.
Szwergold BS; Howell SK; Beisswenger PJ
Ann N Y Acad Sci; 2005 Jun; 1043():845-64. PubMed ID: 16037312
[TBL] [Abstract][Full Text] [Related]
56. Monitoring the protective ability of thymoquinone mixture with p-cymene against bovine serum albumin (BSA) glycation: MCR-ALS analysis based on combined spectroscopic and electrochemical methods.
Benvidi A; Rezaeinasab M; Gharaghani S; Abbasi S
Int J Biol Macromol; 2018 Feb; 107(Pt B):2465-2474. PubMed ID: 29074084
[TBL] [Abstract][Full Text] [Related]
57. Reversible and covalent binding of 5-(hydroxymethyl)-2-furaldehyde (HMF) with lysine and selected amino acids.
Nikolov PY; Yaylayan VA
J Agric Food Chem; 2011 Jun; 59(11):6099-107. PubMed ID: 21557617
[TBL] [Abstract][Full Text] [Related]
58. Non-enzymatic glycation of proteins: a cause for complications in diabetes.
Nawale RB; Mourya VK; Bhise SB
Indian J Biochem Biophys; 2006 Dec; 43(6):337-44. PubMed ID: 17285797
[TBL] [Abstract][Full Text] [Related]
59. Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites.
Iberg N; Flückiger R
J Biol Chem; 1986 Oct; 261(29):13542-5. PubMed ID: 3759977
[TBL] [Abstract][Full Text] [Related]
60. Insights into the Progression of Labile Hb A
Mottishaw CR; Becker S; Smith B; Titus G; Holman RW; Rodnick KJ
Hemoglobin; 2019 Jan; 43(1):42-49. PubMed ID: 31060394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
